These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 38288892

  • 1. Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis.
    Maksymowych WP, Baraliakos X, Lambert RG, Landewé R, Sandoval D, Carlier H, Lisse J, Li X, Hojnik M, Østergaard M.
    Lancet Rheumatol; 2022 Sep; 4(9):e626-e634. PubMed ID: 38288892
    [Abstract] [Full Text] [Related]

  • 2. Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial.
    Deodhar A, van der Heijde D, Gensler LS, Kim TH, Maksymowych WP, Østergaard M, Poddubnyy D, Marzo-Ortega H, Bessette L, Tomita T, Leung A, Hojnik M, Gallo G, Li X, Adams D, Carlier H, Sieper J, COAST-X Study Group.
    Lancet; 2020 Jan 04; 395(10217):53-64. PubMed ID: 31813637
    [Abstract] [Full Text] [Related]

  • 3. Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial.
    van der Heijde D, Cheng-Chung Wei J, Dougados M, Mease P, Deodhar A, Maksymowych WP, Van den Bosch F, Sieper J, Tomita T, Landewé R, Zhao F, Krishnan E, Adams DH, Pangallo B, Carlier H, COAST-V study group.
    Lancet; 2018 Dec 08; 392(10163):2441-2451. PubMed ID: 30360964
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis.
    Maksymowych WP, Wichuk S, Dougados M, Jones HE, Pedersen R, Szumski A, Marshall L, Bukowski JF, Lambert RG.
    Ann Rheum Dis; 2018 Jan 08; 77(1):78-84. PubMed ID: 28970212
    [Abstract] [Full Text] [Related]

  • 6. Course of Magnetic Resonance Imaging-Detected Inflammation and Structural Lesions in the Sacroiliac Joints of Patients in the Randomized, Double-Blind, Placebo-Controlled Danish Multicenter Study of Adalimumab in Spondyloarthritis, as Assessed by the Berlin and Spondyloarthritis Research Consortium of Canada Methods.
    Pedersen SJ, Poddubnyy D, Sørensen IJ, Loft AG, Hindrup JS, Thamsborg G, Asmussen K, Hendricks O, Nørregaard J, Piil AD, Møller JM, Jurik AG, Balding L, Lambert RG, Sieper J, Østergaard M.
    Arthritis Rheumatol; 2016 Feb 08; 68(2):418-29. PubMed ID: 26414004
    [Abstract] [Full Text] [Related]

  • 7. MRI evidence of structural changes in the sacroiliac joints of patients with non-radiographic axial spondyloarthritis even in the absence of MRI inflammation.
    Maksymowych WP, Wichuk S, Dougados M, Jones H, Szumski A, Bukowski JF, Marshall L, Lambert RG.
    Arthritis Res Ther; 2017 Jun 06; 19(1):126. PubMed ID: 28587658
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W).
    Dougados M, Wei JC, Landewé R, Sieper J, Baraliakos X, Van den Bosch F, Maksymowych WP, Ermann J, Walsh JA, Tomita T, Deodhar A, van der Heijde D, Li X, Zhao F, Bertram CC, Gallo G, Carlier H, Gensler LS, COAST-V and COAST-W Study Groups.
    Ann Rheum Dis; 2020 Feb 06; 79(2):176-185. PubMed ID: 31685553
    [Abstract] [Full Text] [Related]

  • 9. Postpartum Bone Marrow Edema at the Sacroiliac Joints May Mimic Sacroiliitis of Axial Spondyloarthritis on MRI.
    Agten CA, Zubler V, Zanetti M, Binkert CA, Kolokythas O, Prentl E, Buck FM, Pfirrmann CWA.
    AJR Am J Roentgenol; 2018 Dec 06; 211(6):1306-1312. PubMed ID: 30247978
    [Abstract] [Full Text] [Related]

  • 10. Impact of filgotinib on sacroiliac joint magnetic resonance imaging structural lesions at 12 weeks in patients with active ankylosing spondylitis (TORTUGA trial).
    Maksymowych WP, Østergaard M, Landewé R, Barchuk W, Liu K, Tasset C, Gilles L, Hendrikx T, Besuyen R, Baraliakos X.
    Rheumatology (Oxford); 2022 May 05; 61(5):2063-2071. PubMed ID: 34352069
    [Abstract] [Full Text] [Related]

  • 11. Tumor necrosis factor inhibitor therapy but not standard therapy is associated with resolution of erosion in the sacroiliac joints of patients with axial spondyloarthritis.
    Pedersen SJ, Wichuk S, Chiowchanwisawakit P, Lambert RG, Maksymowych WP.
    Arthritis Res Ther; 2014 Apr 22; 16(2):R100. PubMed ID: 24755322
    [Abstract] [Full Text] [Related]

  • 12. Sacroiliac and spine imaging in spondyloarthritis: Does phenotype or sex matter?
    Pereira GC, Machado NP, Gomes AF, Assad RL, Carneiro FH, Azevedo VF.
    Adv Rheumatol; 2024 Sep 10; 64(1):68. PubMed ID: 39256831
    [Abstract] [Full Text] [Related]

  • 13. Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis.
    Braun J, Blanco R, Marzo-Ortega H, Gensler LS, Van den Bosch F, Hall S, Kameda H, Poddubnyy D, van de Sande M, van der Heijde D, Zhuang T, Stefanska A, Readie A, Richards HB, Deodhar A.
    Arthritis Res Ther; 2023 May 16; 25(1):80. PubMed ID: 37194094
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Deodhar A, Van den Bosch F, Poddubnyy D, Maksymowych WP, van der Heijde D, Kim TH, Kishimoto M, Blanco R, Duan Y, Li Y, Pangan AL, Wung P, Song IH.
    Lancet; 2022 Jul 30; 400(10349):369-379. PubMed ID: 35908570
    [Abstract] [Full Text] [Related]

  • 16. Development and Validation of 3 Preliminary MRI Sacroiliac Joint Composite Structural Damage Scores in a 5-year Longitudinal Axial Spondyloarthritis Study.
    Wetterslev M, Østergaard M, Sørensen IJ, Weber U, Loft AG, Kollerup G, Juul L, Thamsborg G, Madsen OR, Møller JM, Pedersen SJ.
    J Rheumatol; 2021 Oct 30; 48(10):1537-1546. PubMed ID: 33858979
    [Abstract] [Full Text] [Related]

  • 17. Baseline Characteristics and Treatment Response to Ixekizumab Categorised by Sex in Radiographic and Non-radiographic Axial Spondylarthritis Through 52 Weeks: Data from Three Phase III Randomised Controlled Trials.
    van der Horst-Bruinsma IE, de Vlam K, Walsh JA, Bolce R, Hunter T, Sandoval D, Zhu D, Geneus V, Soriano ER, Magrey M.
    Adv Ther; 2022 Jun 30; 39(6):2806-2819. PubMed ID: 35429281
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial.
    Gladman DD, Mease PJ, Bird P, Soriano ER, Chakravarty SD, Shawi M, Xu S, Quinn ST, Gong C, Leibowitz E, Poddubnyy D, Tam LS, Helliwell PS, Kavanaugh A, Deodhar A, Østergaard M, Baraliakos X.
    Trials; 2022 Sep 05; 23(1):743. PubMed ID: 36064592
    [Abstract] [Full Text] [Related]

  • 19. Magnetic Resonance Imaging of Lesions in the Sacroiliac Joints for Differentiation of Patients With Axial Spondyloarthritis From Control Subjects With or Without Pelvic or Buttock Pain: A Prospective, Cross-Sectional Study of 204 Participants.
    Seven S, Østergaard M, Morsel-Carlsen L, Sørensen IJ, Bonde B, Thamsborg G, Lykkegaard JJ, Hendricks O, Jørgensen NR, Pedersen SJ.
    Arthritis Rheumatol; 2019 Dec 05; 71(12):2034-2046. PubMed ID: 31309740
    [Abstract] [Full Text] [Related]

  • 20. Baseline Severity of Sacroiliitis and Extensive Fat Metaplasia Predicts the Progression of Backfill at the Sacroiliac Joint in Patients With Axial Spondyloarthritis.
    Zhang Y, Guo Z, Wang L, Zhan Y, Qu J, Lei X.
    Front Immunol; 2022 Dec 05; 13():887470. PubMed ID: 35833133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.